Discontinuation report ZALTRAP
Report ID | 121390 |
Drug Identification Number | 02421089 |
Brand name | ZALTRAP |
Common or Proper name | AFLIBERCEPT solution |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AFLIBERCEPT |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 8mL vial |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-07-13 |
Remaining supply date | 2016-07-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | last lot 3F007A, expiry 2016-07-31 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-07-30 | French | Compare |
v1 | 2020-07-30 | English | Compare |
Showing 1 to 2 of 2